HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia.

AbstractBACKGROUND:
Preeclampsia is a multisystem disorder of pregnancy, originating in the placenta. Cytochrome P450 (CYP)-dependent eicosanoids regulate vascular function, inflammation, and angiogenesis, which are mechanistically important in preeclampsia.
METHODS AND RESULTS:
We performed microarray screening of placenta and decidua (maternal placenta) from 25 preeclamptic women and 23 control subjects. The CYP subfamily 2J polypeptide 2 (CYP2J2) was upregulated in preeclamptic placenta and decidua. Reverse-transcription polymerase chain reaction confirmed the upregulation, and immunohistochemistry localized CYP2J2 in trophoblastic villi and deciduas at 12 weeks and term. The CYP2J2 metabolites, 5,6-epoxyeicosatrienoic acid (EET), 14,15-EET, and the corresponding dihydroxyeicosatrienoic acids, were elevated in preeclamptic women compared with controls in the latter two thirds of pregnancy and after delivery. Stimulating a trophoblast-derived cell line with the preeclampsia-associated cytokine tumor necrosis factor-α enhanced CYP2J2 gene and protein expression. In 2 independent rat models of preeclampsia, reduced uterine-perfusion rat and the transgenic angiotensin II rat, we observed elevated EET, dihydroxyeicosatrienoic acid, and preeclamptic features that were ameliorated by the CYP epoxygenase inhibitor N-(methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide (MsPPOH). Uterine arterial rings of these rats also dilated in response to MsPPOH. Furthermore, 5,6-EET could be metabolized to a thromboxane analog. In a bioassay, 5,6-EET increased the beating rate of neonatal cardiomyocytes. Blocking thromboxane synthesis reversed that finding and also normalized large-conductance calcium-activated potassium channel activity.
CONCLUSIONS:
Our data implicate CYP2J2 in the pathogenesis of preeclampsia and as a potential candidate for the disturbed uteroplacental remodeling, leading to hypertension and endothelial dysfunction.
AuthorsFlorian Herse, Babbette Lamarca, Carl A Hubel, Tea Kaartokallio, A Inkeri Lokki, Eeva Ekholm, Hannele Laivuori, Martin Gauster, Berthold Huppertz, Meryam Sugulle, Michael J Ryan, Sarah Novotny, Justin Brewer, Joon-Keun Park, Michael Kacik, Joachim Hoyer, Stefan Verlohren, Gerd Wallukat, Michael Rothe, Friedrich C Luft, Dominik N Muller, Wolf-Hagen Schunck, Anne C Staff, Ralf Dechend
JournalCirculation (Circulation) Vol. 126 Issue 25 Pg. 2990-9 (Dec 18 2012) ISSN: 1524-4539 [Electronic] United States
PMID23155181 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Bridged Bicyclo Compounds, Heterocyclic
  • CYP2J2 protein, human
  • Fatty Acids, Unsaturated
  • Hydrazines
  • KCNMA1 protein, human
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
  • 5,6-epoxy-8,11,14-eicosatrienoic acid
  • 14,15-epoxy-5,8,11-eicosatrienoic acid
  • SQ 29548
  • Cytochrome P-450 Enzyme System
  • Cytochrome P-450 CYP2J2
  • 8,11,14-Eicosatrienoic Acid
Topics
  • 8,11,14-Eicosatrienoic Acid (analogs & derivatives, blood, pharmacology)
  • Animals
  • Bridged Bicyclo Compounds, Heterocyclic
  • Cells, Cultured
  • Cytochrome P-450 CYP2J2
  • Cytochrome P-450 Enzyme System (analysis, genetics, physiology)
  • Fatty Acids, Unsaturated
  • Female
  • Humans
  • Hydrazines (pharmacology)
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits (physiology)
  • Oligonucleotide Array Sequence Analysis
  • Placenta (blood supply)
  • Polymorphism, Single Nucleotide
  • Pre-Eclampsia (blood, enzymology, etiology)
  • Pregnancy
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: